Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Convergent large-scale network and local vulnerabilities underlie brain atrophy across Parkinson's disease stages: a worldwide ENIGMA study.
Vo A, Tremblay C, Rahayel S, Al-Bachari S, Berendse HW, Bright JK, Cendes F, d'Angremont E, Dalrymple-Alford JC, Debove I, Dirkx MF, Druzgal J, Garraux G, Helmich RC, Hu M, Jahanshad N, Johansson ME, Klein JC, Laansma MA, McMillan CT, Melzer TR, Misic B, Mosley P, Owens-Walton C, Parkes LM, Pellicano C, Piras F, Poston KL, Rango M, Rummel C, Schwingenschuh P, Suette M, Thompson PM, Tosun D, Tsai CC, van Balkom TD, van den Heuvel OA, van der Werf YD, van Heese EM, Vriend C, Wang JJ, Wiest R, Yasuda C, Dagher A; ENIGMA-Parkinson’s Study. Vo A, et al. Among authors: d angremont e. medRxiv [Preprint]. 2025 May 29:2025.05.25.25326586. doi: 10.1101/2025.05.25.25326586. medRxiv. 2025. PMID: 40492073 Free PMC article. Preprint.
Neuroimaging-based data-driven subtypes of spatiotemporal atrophy due to Parkinson's disease.
Shawa Z, Shand C, Taylor B, Berendse HW, Vriend C, van Balkom TD, van den Heuvel OA, van der Werf YD, Wang JJ, Tsai CC, Druzgal J, Newman BT, Melzer TR, Pitcher TL, Dalrymple-Alford JC, Anderson TJ, Garraux G, Rango M, Schwingenschuh P, Suette M, Parkes LM, Al-Bachari S, Klein J, Hu MTM, McMillan CT, Piras F, Vecchio D, Pellicano C, Zhang C, Poston KL, Ghasemi E, Cendes F, Yasuda CL, Tosun D, Mosley P, Thompson PM, Jahanshad N, Owens-Walton C, d'Angremont E, van Heese EM, Laansma MA, Altmann A; ENIGMA Parkinson’s Disease Working Group; Weil RS, Oxtoby NP. Shawa Z, et al. Among authors: d angremont e. Brain Commun. 2025 Apr 16;7(2):fcaf146. doi: 10.1093/braincomms/fcaf146. eCollection 2025. Brain Commun. 2025. PMID: 40303603 Free PMC article.
Therapeutic effect of an inhaled levodopa dry powder formulation on off episodes in patients with Parkinson's disease.
de Jong L, Luinstra M, Aalbers AF, Wijma-Vos AJ, D'Angremont E, van der Meulen AAE, Rutgers AWF, Steenhuis L, Hagedoorn P, van Laar T, Frijlink HW. de Jong L, et al. Among authors: d angremont e. Ther Adv Neurol Disord. 2024 Oct 25;17:17562864241289207. doi: 10.1177/17562864241289207. eCollection 2024. Ther Adv Neurol Disord. 2024. PMID: 39483816 Free PMC article.
13 results